Point-of-care Testing with High-sensitivity Cardiac Troponin Assays: the Challenges and Opportunities

Overview

Journal Emerg Med J

Specialty Emergency Medicine

Date 2022 Jan 12

PMID 35017187

Authors

Louise Cullen

Paul O Collinson

Evangelos Giannitsis

Affiliations

Soon will be listed here.

Abstract

Methods to improve the safety, accuracy and efficiency of assessment of patients with suspected acute coronary symptoms have occupied decades of study and have supported significant changes in clinical practice. Much of the progress is reliant on results of laboratory-based high-sensitivity cardiac troponin assays that can detect low concentrations with high precision. Until recently, point-of-care (POC) platforms were unable to perform with similar analytical precision as laboratory-based assays, and recommendations for their use in accelerated assessment strategies for patients with suspected acute coronary syndrome has been limited. As POC assays can provide troponin results within 20 min, and can be used proximate to patient care, improvements in the efficiency of assessment of patients with suspected acute coronary syndrome is possible, particularly with new high-sensitivity assays.

Citing Articles

Patient-centred newer testing methods for major cardiac disorders.

Kumar R, Tamizhan S, Darbari A, Naithani M, Malik S, Yadav N Indian J Thorac Cardiovasc Surg. 2025; 41(2):167-174.

PMID: 39822862 PMC: 11732823. DOI: 10.1007/s12055-024-01850-2.

Point of care testing for high-sensitive troponin measurement: experience from a tertiary care hospital clinical laboratory.

El Amrani S, Tossens B, Van Belle L, Gonda J, Midoun S, Beauloye C Adv Lab Med. 2024; 5(4):455-458.

PMID: 39713542 PMC: 11661533. DOI: 10.1515/almed-2024-0058.

El Amrani S, Tossens B, Van Belle L, Gonda J, Midoun S, Beauloye C Adv Lab Med. 2024; 5(4):459-462.

PMID: 39713536 PMC: 11661536. DOI: 10.1515/almed-2024-0151.

Clinical Laboratory Validation Study of a High Sensitivity Troponin I Assay on a POCT (Point of Care Testing) Device.

Pitta F, Leme A, Gomes S, Mota T, Paladino F, de Souza Junior J Glob Heart. 2024; 19(1):96.

PMID: 39713195 PMC: 11661013. DOI: 10.5334/gh.1377.

Emergency department use of a high-sensitivity point-of-care troponin assay reduces length of stay: an implementation study preliminary report.

Pickering J, Joyce L, Florkowski C, Buchan V, Hamill L, Than M Eur Heart J Acute Cardiovasc Care. 2024; 13(12):838-842.

PMID: 39403951 PMC: 11666305. DOI: 10.1093/ehjacc/zuae114.

References

Apple F, Collinson P . Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2011; 58(1):54-61. DOI: 10.1373/clinchem.2011.165795. View

Greenslade J, Parsonage W, Foran L, McCormack L, Ashover S, Milburn T . Widespread Introduction of a High-Sensitivity Troponin Assay: Assessing the Impact on Patients and Health Services. J Clin Med. 2020; 9(6). PMC: 7356092. DOI: 10.3390/jcm9061883. View

Body R, Almashali M, Morris N, Moss P, Jarman H, Appelboam A . Diagnostic accuracy of the T-MACS decision aid with a contemporary point-of-care troponin assay. Heart. 2019; 105(10):768-774. DOI: 10.1136/heartjnl-2018-313825. View

Goodacre S, Bradburn M, Cross E, Collinson P, Gray A, Hall A . The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart. 2010; 97(3):190-6. DOI: 10.1136/hrt.2010.203166. View

Stopyra J, Snavely A, Scheidler J, Smith L, Nelson R, Winslow J . Point-of-Care Troponin Testing during Ambulance Transport to Detect Acute Myocardial Infarction. Prehosp Emerg Care. 2020; 24(6):751-759. DOI: 10.1080/10903127.2020.1721740. View

Pickering J, Than M, Cullen L, Aldous S, Avest E, Body R . Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. Ann Intern Med. 2017; 166(10):715-724. DOI: 10.7326/M16-2562. View

Than M, Cullen L, Reid C, Lim S, Aldous S, Ardagh M . A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011; 377(9771):1077-84. DOI: 10.1016/S0140-6736(11)60310-3. View

Chew D, Lambrakis K, Blyth A, Seshadri A, Edmonds M, Briffa T . A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT). Circulation. 2019; 140(19):1543-1556. DOI: 10.1161/CIRCULATIONAHA.119.042891. View

Stoyanov K, Hund H, Biener M, Gandowitz J, Riedle C, Lohr J . RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019; 9(1):39-51. PMC: 7008552. DOI: 10.1177/2048872619861911. View

10.

Apple F, Chung A, Kogut M, Bubany S, Murakami M . Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta. 2006; 370(1-2):191-5. DOI: 10.1016/j.cca.2006.02.011. View

11.

Eggers K, Jernberg T, Lindahl B . Cardiac Troponin Elevation in Patients Without a Specific Diagnosis. J Am Coll Cardiol. 2019; 73(1):1-9. DOI: 10.1016/j.jacc.2018.09.082. View

12.

Shah A, Anand A, Strachan F, Ferry A, Lee K, Chapman A . High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018; 392(10151):919-928. PMC: 6137538. DOI: 10.1016/S0140-6736(18)31923-8. View

13.

Apple F, Schulz K, Schmidt C, van Domburg T, Fonville J, de Theije F . Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay. Clin Chem Lab Med. 2021; 59(9):1574-1578. DOI: 10.1515/cclm-2021-0262. View

14.

Boeddinghaus J, Nestelberger T, Koechlin L, Wussler D, Lopez-Ayala P, Walter J . Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I. J Am Coll Cardiol. 2020; 75(10):1111-1124. DOI: 10.1016/j.jacc.2019.12.065. View

15.

. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation. 1979; 59(3):607-9. DOI: 10.1161/01.cir.59.3.607. View

16.

Gopi V, Milles B, Spanuth E, Muller-Hennessen M, Biener M, Stoyanov K . Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples. Clin Chem Lab Med. 2021; 59(9):1579-1584. DOI: 10.1515/cclm-2021-0354. View

17.

Apple F, Murakami M, Christenson R, Campbell J, Miller C, Hock K . Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta. 2004; 345(1-2):123-7. DOI: 10.1016/j.cccn.2004.03.010. View

18.

Thygesen K, Alpert J, White H, Jaffe A, Apple F, Galvani M . Universal definition of myocardial infarction. Circulation. 2007; 116(22):2634-53. DOI: 10.1161/CIRCULATIONAHA.107.187397. View

19.

Pickering J, Young J, George P, Watson A, Aldous S, Troughton R . Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction. JAMA Cardiol. 2018; 3(11):1108-1112. PMC: 6583693. DOI: 10.1001/jamacardio.2018.3368. View

20.

Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138(20):e618-e651. DOI: 10.1161/CIR.0000000000000617. View